Figure 1
Figure 1. Outcomes after transplantation according to donor source. The rate of DFS (A) and the rate of OS (B). (C) The incidence of NRM. (D) The incidence of relapse. The incidence of neutrophil engraftment (>500 neutrophils per mm3) (E) and the incidence of platelet engraftment (>20 000 platelets per cubic mm3, without platelet transfusion during the prior 7 days) (F). The incidence of acute GVHD of grades 2 to 4 (G) and the incidence of chronic GVHD (H).

Outcomes after transplantation according to donor source. The rate of DFS (A) and the rate of OS (B). (C) The incidence of NRM. (D) The incidence of relapse. The incidence of neutrophil engraftment (>500 neutrophils per mm3) (E) and the incidence of platelet engraftment (>20 000 platelets per cubic mm3, without platelet transfusion during the prior 7 days) (F). The incidence of acute GVHD of grades 2 to 4 (G) and the incidence of chronic GVHD (H).

Close Modal

or Create an Account

Close Modal
Close Modal